Leg­endary biotech leader pass­es away, re­newed ten­sion around ad­u­canum­ab, Mer­ck­'s rare de­feat, and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

For many of our read­ers, we wish you are en­joy­ing your East­er break and not nec­es­sar­i­ly read­ing this is­sue over the week­end. But if you’re keen to tune in­to every twist and turn in bio­phar­ma land, here’s a re­minder that Zach Bren­nan is launch­ing the week­ly End­points FDA+ re­port in April. You can sign up at the same place here.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER